Skip to main content
logo
AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
4.090
-0.310 (-7.05%)
At close: May 15, 2026, 4:00 PM EDT
4.240
+0.150 (3.67%)
Pre-market: May 18, 2026, 7:38 AM EDT

AbCellera Biologics Revenue

AbCellera Biologics had revenue of $8.32M in the quarter ending March 31, 2026, with 96.34% growth. This brings the company's revenue in the last twelve months to $79.21M, up 242.66% year-over-year. In the year 2025, AbCellera Biologics had annual revenue of $75.13M with 160.56% growth.

Revenue (ttm)
$79.21M
Revenue Growth
+242.66%
P/S Ratio
15.76
Revenue / Employee
$140,940
Employees
562
Market Cap
1.25B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202575.13M46.30M160.56%
Dec 31, 202428.83M-9.19M-24.17%
Dec 31, 202338.03M-447.40M-92.17%
Dec 31, 2022485.42M110.22M29.38%
Dec 31, 2021375.20M142.05M60.92%
Dec 31, 2020233.16M221.54M1,907.88%
Dec 31, 201911.61M2.78M31.49%
Dec 31, 20188.83M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

ABCL News

More News